Research Progress of Bioavailability of Oral Drugs Based on the Gut Microbiota

被引:0
|
作者
Li, Huifang [1 ]
Yuan, Tianjie [1 ]
Jiang, Shu [1 ]
机构
[1] School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing,210046, China
关键词
Bioavailability - Drug metabolisms - Expression levels - Gut microbiota - High safety - Intestinal tract - Oral administration - Oral bioavailabilities - Probiotics - Therapeutic properties;
D O I
10.16522/j.cnki.cjph.2022.09.004
中图分类号
学科分类号
摘要
Oral administration, with the characteristics of high safety and economic convenience, is one of the most common ways of drug delivery. However, the substantial discrepancy between potent therapeutic properties of various medicines and their low oral bioavailability limits their application. In recent years, researches have revealed that gut microbiota, which act as a practical bioreactor in the human intestinal tract, have an essential effect on the discrepancy. In addition to directly participating in drug metabolism through biotransformation, gut microbiota can also indirectly affect bioavailability of oral drugs by regulating the expression levels of host liver metabolic enzymes and the transporters. This review briefly introduces the factors affecting drug bioavailability, and mainly discusses the effects of gut microbiota and probiotics on drug oral bioavailability to provide a reference for understanding the relationship between gut microbiota and drug oral bioavailability, and developing novel strategies for improving drug oral bioavailability. © 2022 Shanghai Institute of Pharmaceutical Industry. All rights reserved.
引用
收藏
页码:1262 / 1269
相关论文
共 50 条
  • [1] The influence of the gut microbiota on the bioavailability of oral drugs
    Xintong Zhang
    Ying Han
    Wei Huang
    Mingji Jin
    Zhonggao Gao
    [J]. Acta Pharmaceutica Sinica B, 2021, 11 (07) : 1789 - 1812
  • [2] The influence of the gut microbiota on the bioavailability of oral drugs
    Zhang, Xintong
    Han, Ying
    Huang, Wei
    Jin, Mingji
    Gao, Zhonggao
    [J]. ACTA PHARMACEUTICA SINICA B, 2021, 11 (07) : 1789 - 1812
  • [3] Research Progress of Biomimetic Nanocarriers in Improving Bioavailability of Oral Drugs
    An, Qiuxu
    Huo, Daixia
    Liu, Yuanyuan
    Lyu, Xiaojie
    [J]. Chinese Journal of Pharmaceuticals, 2023, 54 (11) : 1542 - 1552
  • [4] Bioavailability Based on the Gut Microbiota: a New Perspective
    Zhang, Feng
    He, Fang
    Li, Li
    Guo, Lichun
    Zhang, Bin
    Yu, Shuhuai
    Zhao, Wei
    [J]. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2020, 84 (02)
  • [5] Research progress of gut microbiota in hepatocellular carcinoma
    Li, Keliu
    Liu, Jianhua
    Qin, Xiaosong
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (07)
  • [6] Research progress of gut microbiota and frailty syndrome
    Wang, Xiao
    Wu, Min
    [J]. OPEN MEDICINE, 2021, 16 (01): : 1525 - 1536
  • [7] Research progress on the effect of gut and tumor microbiota on antitumor efficacy and adverse effects of chemotherapy drugs
    Yin, Beibei
    Wang, Xuan
    Yuan, Fang
    Li, Yan
    Lu, Ping
    [J]. FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [8] Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen, Feng
    Wen, Qi
    Jiang, Jun
    Li, Hai-Long
    Tan, Yin-Feng
    Li, Yong-Hui
    Zeng, Nian-Kai
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2016, 179 : 253 - 264
  • [9] Research Progress in the Interaction between Flavonoids and Gut Microbiota
    Chen B.
    Liu J.
    Zhan M.
    Lil M.
    Cao Y.
    Song M.
    [J]. Journal of Chinese Institute of Food Science and Technology, 2022, 22 (06) : 369 - 381
  • [10] Research Progress on the Correlation Between Hypertension and Gut Microbiota
    Cui, Xiaomei
    Zhang, Ting
    Xie, Tao
    Guo, Fang-xi
    Zhang, Yu-ying
    Deng, Yuan-jia
    Wang, Qi
    Guo, Yi-xing
    Dong, Ming-hua
    Luo, Xiao-ting
    [J]. JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2024, 17 : 2371 - 2387